Clinical Trial

Fetoscopic Endoluminal Tracheal Occlusion

Study acronym: FETO
Recruiting
View on ClinicalTrials.gov →
Summary
This is a single site pilot trial to study the feasibility of Fetoscopic Endoluminal Tracheal Occlusion (FETO) therapy in the most severe group of fetuses with congenital diaphragmatic hernia (CDH) at Midwest Fetal Care Center, a collaboration between Allina Health and Children's Minnesota. This procedure aims to increase fetal lung volume before birth and improve survival after birth. This study will enroll 10 pregnant people and their baby who meet study criteria.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-14.
Trial Details
NCT Number NCT05771688
Lead Sponsor Children's Hospitals and Clinics of Minnesota
Collaborators: Allina Health System
Conditions Hernia, DIaphragmatic, Congenital
Enrollment 10 participants
Start Date 2024-02-22
Primary Completion 2028-02 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2024-02-23